PWMG
CDMO

Prestige Wealth Management Group’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Prestige Wealth Management Group’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-58
Closed – – 1059
2020
Q3 		$0 Hold
58
– – ﹤0.01% 929
2020
Q2 		$0 Hold
58
– – ﹤0.01% 977
2020
Q1 		$0 Buy
+58
New +$351 ﹤0.01% 1030

Other funds holding CDMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Prestige Wealth Management Group's CDMO Position: Q4 2020 in Review

Prestige Wealth Management Group sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q4 2020, closing a stake of 58 shares.

Prestige Wealth Management Group first reported a position in CDMO in Q1 2020 and held it in 3 quarters. The position peaked at $0 in Q3 2020. 147 funds tracked by Wall St. Rank hold CDMO as of Q4 2020.

  • Prestige Wealth Management Group reported no remaining Avid Bioservices, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Prestige Wealth Management Group sold 58 Avid Bioservices, Inc. Common Stock shares in Q4 2020.
  • Prestige Wealth Management Group first reported a position in Avid Bioservices, Inc. Common Stock in Q1 2020 and held it in 3 quarters.
  • Prestige Wealth Management Group's Avid Bioservices, Inc. Common Stock position peaked at $0 in Q3 2020.
  • 147 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2020.

Based on Prestige Wealth Management Group's 13F filing for Q4 2020, filed 17 Feb 2021.